ArticleFrontiers in immunology2025

Aberrant expression of PYGB as a potential therapeutic target and its associations with immune cell infiltration in lung cancer.

Kai Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.